Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolite-driven remodeling of hepatic lipid metabolism by the plasticizer di-isononyl phthalate.

Molecular metabolism·2026
Same author

Functional polymorphisms in pigmentation-related genes <i>MC1R</i> and <i>DCT</i> display population-specific association with wet age-related macular degeneration.

Biochemistry and biophysics reports·2026
Same author

Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies.

Open research Europe·2026
Same author

Drug-Free Approach to Regulate Undruggable Proto-Oncogene MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy.

ACS applied materials & interfaces·2025
Same author

Nuclear receptors CAR and PXR as cardiometabolic regulators.

Pharmacological research·2025
Same author

Selection of locally administered ocular tissue-targeting RNA aptamers using in vivo SELEX.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025

Related Experiment Video

Updated: Apr 6, 2026

Author Spotlight: Advancements in Synthetic Genetic Devices for Stem Cell Fate Manipulation and Cellular Therapy Development
06:04

Author Spotlight: Advancements in Synthetic Genetic Devices for Stem Cell Fate Manipulation and Cellular Therapy Development

Published on: December 8, 2023

1.7K

Improved assays for xenosensor activation based on reverse transfection.

Jenni Küblbeck1, Teemu Anttila1, Juha T Pulkkinen1

  • 1School of Pharmacy and Biocenter Kuopio, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.

Toxicology in Vitro : an International Journal Published in Association with BIBRA
|July 19, 2015
PubMed
Summary

A new reverse transfection system streamlines drug metabolism studies by reliably measuring the activation of key human xenosensors (AhR, CAR, PXR). This method enhances the prediction of drug-induced cytochrome P450 enzyme activity during early drug development.

Keywords:
Aryl hydrocarbon receptorConstitutive androstane receptorCytochrome P450InductionPregnane X receptorReverse transfection

More Related Videos

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.8K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

13.2K

Related Experiment Videos

Last Updated: Apr 6, 2026

Author Spotlight: Advancements in Synthetic Genetic Devices for Stem Cell Fate Manipulation and Cellular Therapy Development
06:04

Author Spotlight: Advancements in Synthetic Genetic Devices for Stem Cell Fate Manipulation and Cellular Therapy Development

Published on: December 8, 2023

1.7K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.8K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

13.2K

Area of Science:

  • Pharmacology
  • Biotechnology
  • Drug Metabolism

Background:

  • Receptor-dependent mechanisms regulate drug metabolism, influencing cytochrome P450 enzyme induction.
  • Receptor-based reporter assays are crucial for early drug development and mechanistic studies.
  • Conventional transfection methods can introduce variability and require multiple steps.

Purpose of the Study:

  • To develop and validate a novel reverse transfection system for activation assays of human xenosensors.
  • To improve the reproducibility and efficiency of assays for predicting drug-induced CYP enzyme activity.
  • To provide a streamlined method for evaluating species differences and conducting mechanistic studies in drug development.

Main Methods:

  • A reverse transfection system utilizing stable DNA/carrier complexes on culture plates.
  • Activation assays for human aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), and pregnane X receptor (PXR).
  • Formal validation of the assay system with Z' factors exceeding 0.5.

Main Results:

  • The reverse transfection system demonstrated long-term stability and uniformity.
  • The assay format avoided multiple stages and reduced inherent variations compared to conventional methods.
  • The system proved to be streamlined, reproducible, and formally validated.

Conclusions:

  • The novel reverse transfection system offers a robust and efficient method for studying xenosensor activation.
  • This system is valuable for predicting cytochrome P450 induction and evaluating species differences in early drug development.
  • The validated assay is expected to be widely applicable in various aspects of preclinical drug safety assessment.